CN103108654A - 多价糖肽构建体及其用途 - Google Patents
多价糖肽构建体及其用途 Download PDFInfo
- Publication number
- CN103108654A CN103108654A CN2011800392591A CN201180039259A CN103108654A CN 103108654 A CN103108654 A CN 103108654A CN 2011800392591 A CN2011800392591 A CN 2011800392591A CN 201180039259 A CN201180039259 A CN 201180039259A CN 103108654 A CN103108654 A CN 103108654A
- Authority
- CN
- China
- Prior art keywords
- glycopeptide
- independently
- group
- cancer
- immunogenic carrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- BDRUNZOXYBAMBR-UHFFFAOYSA-N CC(CCOC)CC(C(C)=O)NC Chemical compound CC(CCOC)CC(C(C)=O)NC BDRUNZOXYBAMBR-UHFFFAOYSA-N 0.000 description 1
- DJOOYUHKMPPNBO-UHFFFAOYSA-N CCC(C)NC(CC(C)COC)C(C)O Chemical compound CCC(C)NC(CC(C)COC)C(C)O DJOOYUHKMPPNBO-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001169—Tumor associated carbohydrates
- A61K39/001171—Gangliosides, e.g. GM2, GD2 or GD3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35372210P | 2010-06-11 | 2010-06-11 | |
| US61/353,722 | 2010-06-11 | ||
| PCT/US2011/040074 WO2011156774A2 (en) | 2010-06-11 | 2011-06-10 | Multivalent glycopeptide constructs and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103108654A true CN103108654A (zh) | 2013-05-15 |
Family
ID=45098716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011800392591A Pending CN103108654A (zh) | 2010-06-11 | 2011-06-10 | 多价糖肽构建体及其用途 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9493580B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2579893A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6050227B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN103108654A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011265184B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2801922A1 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ604089A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011156774A2 (cg-RX-API-DMAC7.html) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108026134A (zh) * | 2015-09-16 | 2018-05-11 | 巴塞尔大学 | 结合抗糖鞘脂糖蛋白表位抗体的碳水化合物配体 |
| CN108350605A (zh) * | 2015-09-04 | 2018-07-31 | 台湾浩鼎生技股份有限公司 | 聚糖阵列以及使用方法 |
| TWI641383B (zh) * | 2013-09-17 | 2018-11-21 | 台灣浩鼎生技股份有限公司 | 碳水化合物疫苗之化合物及組成物以及其用途 |
| US10980894B2 (en) | 2016-03-29 | 2021-04-20 | Obi Pharma, Inc. | Antibodies, pharmaceutical compositions and methods |
| US11000601B2 (en) | 2016-11-21 | 2021-05-11 | Obi Pharma, Inc. | Conjugated biological molecules, pharmaceutical compositions and methods |
| US11041017B2 (en) | 2016-03-29 | 2021-06-22 | Obi Pharma, Inc. | Antibodies, pharmaceutical compositions and methods |
| US11203645B2 (en) | 2018-06-27 | 2021-12-21 | Obi Pharma, Inc. | Glycosynthase variants for glycoprotein engineering and methods of use |
| US11220523B2 (en) | 2014-03-13 | 2022-01-11 | Universität Basel | Carbohydrate ligands that bind to IgM antibodies against myelin-associated glycoprotein |
| US11583577B2 (en) | 2016-04-22 | 2023-02-21 | Obi Pharma, Inc. | Cancer immunotherapy by immune activation or immune modulation via Globo series antigens |
| US11642400B2 (en) | 2016-07-27 | 2023-05-09 | Obi Pharma, Inc. | Immunogenic/therapeutic glycan compositions and uses thereof |
| US11643456B2 (en) | 2016-07-29 | 2023-05-09 | Obi Pharma, Inc. | Human antibodies, pharmaceutical compositions and methods |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE325803T1 (de) | 1999-08-20 | 2006-06-15 | Sloan Kettering Inst Cancer | Glycokonjugate, glycoaminosäure, deren zwischenprodukte, und ihre verwendung |
| WO2010006343A2 (en) | 2008-07-11 | 2010-01-14 | Sloan-Kettering Institute For Cancer Research | Glycopeptide constructs and uses thereof |
| US8900635B2 (en) | 2010-11-15 | 2014-12-02 | Humanetics Corporation | Nanoparticle isoflavone compositions and methods of making and using the same |
| MX2015004171A (es) * | 2012-10-02 | 2015-10-22 | Glaxosmithkline Biolog Sa | Conjugados de sacaridos no lineales. |
| CA2897084C (en) * | 2013-01-04 | 2019-07-16 | Cheng Der Tony Yu | Vaccines with higher carbohydrate antigen density and novel saponin adjuvant |
| WO2015048408A1 (en) * | 2013-09-27 | 2015-04-02 | Virginia Tech Intellectual Properties, Inc. | Cross-metathesized polysaccharide derivatives and processes for preparing them |
| US9084726B2 (en) * | 2013-11-26 | 2015-07-21 | Humanetics Corporation | Suspension compositions of physiologically active phenolic compounds and methods of making and using the same |
| WO2015139029A2 (en) | 2014-03-14 | 2015-09-17 | Virginia Tech Intellectual Properties, Inc. | Polysaccharide derivatives and cross-metathesis processes for preparing them |
| TW201622743A (zh) | 2014-03-19 | 2016-07-01 | 財團法人臺灣基督長老教會馬偕紀念社會事業基金會馬偕紀念醫院 | 免疫原醣肽、包含該醣肽之組合物及其用途 |
| JP6590474B2 (ja) * | 2014-09-25 | 2019-10-16 | 国立大学法人埼玉大学 | 化学架橋ペプチドの作製方法、その方法を用いて作製した化学架橋ペプチド及びそのペプチドを用いて構築したcDNAディスプレイ法によるペプチドライブラリ |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010006343A2 (en) * | 2008-07-11 | 2010-01-14 | Sloan-Kettering Institute For Cancer Research | Glycopeptide constructs and uses thereof |
| WO2010005598A1 (en) * | 2008-06-16 | 2010-01-14 | Academia Sinica | Globo h and related anti-cancer vaccines with novel glycolipid adjuvants |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5576894A (en) | 1978-12-05 | 1980-06-10 | Towa Kasei Kogyo Kk | Epimerization of aldose |
| ES2097840T3 (es) | 1987-11-03 | 1997-04-16 | Syntex Inc | Adyuvante de vacuna que comprende un tetrapoliol. |
| US6303120B1 (en) | 1994-03-15 | 2001-10-16 | Memorial Sloan-Kettering Institute For Cancer Research | Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
| US5708163A (en) | 1994-03-15 | 1998-01-13 | Sloan-Kettering Institute Of Cancer Research | Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof |
| US6184344B1 (en) | 1995-05-04 | 2001-02-06 | The Scripps Research Institute | Synthesis of proteins by native chemical ligation |
| CA2277867A1 (en) | 1997-01-13 | 1998-07-16 | Sloan-Kettering Institute For Cancer Research | Colon cancer kh-1 and n3 antigens |
| EP0996455B1 (en) | 1997-04-16 | 2009-12-16 | Sloan-Kettering Institute For Cancer Research | Alpha-o-linked glycoconjugates with clustered (2,6)-st epitopes, methods of preparation and uses thereof |
| US7550146B2 (en) | 1997-04-16 | 2009-06-23 | Sloan-Kettering Institute For Cancer Research | Glycopeptide conjugates and uses thereof |
| US6080725A (en) | 1997-05-20 | 2000-06-27 | Galenica Pharmaceuticals, Inc. | Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof |
| NZ500779A (en) | 1997-05-20 | 2001-06-29 | Galenica Pharmaceuticals Inc | Triterpene saponin analogs having adjuvant and immunostimulatory activity |
| JPH1135594A (ja) | 1997-07-24 | 1999-02-09 | Meiji Milk Prod Co Ltd | ムチン型糖鎖合成中間体 |
| AU745555B2 (en) | 1997-09-25 | 2002-03-21 | Sloan-Kettering Institute For Cancer Research | Fucosyl GM1-KLH conjugate vaccine against small cell lung cancer |
| DE19802748A1 (de) | 1998-01-26 | 1999-07-29 | Chemtec Leuna Ges Fuer Chemie | Verfahren zur enzymatischen Synthese von Glycoaminosäurederivaten |
| US7018637B2 (en) | 1998-02-23 | 2006-03-28 | Aventis Pasteur, Inc | Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| EP1091751A4 (en) | 1998-03-25 | 2005-01-19 | Sloan Kettering Institutefor C | TRIMERIC OXYGENIC BINDING GLYCOPEPTIDE CONJUGATES, METHODS OF PREPARATION AND USE THEREOF |
| WO1999061916A1 (en) | 1998-05-29 | 1999-12-02 | Epimmune, Inc. | Identification of broadly reactive dr restricted epitopes |
| US7854934B2 (en) * | 1999-08-20 | 2010-12-21 | Sloan-Kettering Institute For Cancer Research | Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof |
| ATE325803T1 (de) | 1999-08-20 | 2006-06-15 | Sloan Kettering Inst Cancer | Glycokonjugate, glycoaminosäure, deren zwischenprodukte, und ihre verwendung |
| US7824687B2 (en) | 1999-08-20 | 2010-11-02 | Sloan-Kettering Institute For Cancer Research | Clustered multi-antigenic carbohydrate constructs, methods for their preparation, and uses thereof |
| US7118737B2 (en) | 2000-09-08 | 2006-10-10 | Amylin Pharmaceuticals, Inc. | Polymer-modified synthetic proteins |
| WO2003003985A2 (en) * | 2001-07-06 | 2003-01-16 | Sloan-Kettering Institute For Cancer Research | Polyvalent conjugate vaccine for cancer |
| WO2004050711A2 (en) | 2002-12-03 | 2004-06-17 | Sloan-Kettering Institute For Cancer Research | Gp120 specific antigens, conjugates thereof, methods for their preparation and uses thereof |
| WO2004060915A2 (en) | 2002-12-03 | 2004-07-22 | Sloan-Kettering Institute For Cancer Research | Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof. |
| JP2007527864A (ja) | 2003-09-05 | 2007-10-04 | スローン − ケッタリング インスティチュート フォー キャンサー リサーチ | 自然に起こる化学的連結による、多官能化ペプチドおよび/またはタンパク質の調製方法 |
| WO2007079448A2 (en) | 2006-01-03 | 2007-07-12 | University Of Georgia Research Foundation, Inc. | Three component carbohydrate vaccine |
| AU2007258550B2 (en) | 2006-06-08 | 2013-09-19 | University Of Georgia Research Foundation, Inc. | Liposome-mediated native chemical ligation |
-
2011
- 2011-06-10 CA CA2801922A patent/CA2801922A1/en not_active Abandoned
- 2011-06-10 US US13/703,563 patent/US9493580B2/en not_active Expired - Fee Related
- 2011-06-10 EP EP11793286.3A patent/EP2579893A4/en not_active Withdrawn
- 2011-06-10 AU AU2011265184A patent/AU2011265184B2/en not_active Ceased
- 2011-06-10 JP JP2013514400A patent/JP6050227B2/ja not_active Expired - Fee Related
- 2011-06-10 NZ NZ604089A patent/NZ604089A/en not_active IP Right Cessation
- 2011-06-10 WO PCT/US2011/040074 patent/WO2011156774A2/en not_active Ceased
- 2011-06-10 CN CN2011800392591A patent/CN103108654A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010005598A1 (en) * | 2008-06-16 | 2010-01-14 | Academia Sinica | Globo h and related anti-cancer vaccines with novel glycolipid adjuvants |
| WO2010006343A2 (en) * | 2008-07-11 | 2010-01-14 | Sloan-Kettering Institute For Cancer Research | Glycopeptide constructs and uses thereof |
Non-Patent Citations (1)
| Title |
|---|
| JIANGLONG ZHU ET AL.: "From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine", 《J.AM.CHEM.SOC.》 * |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI641383B (zh) * | 2013-09-17 | 2018-11-21 | 台灣浩鼎生技股份有限公司 | 碳水化合物疫苗之化合物及組成物以及其用途 |
| US12053514B2 (en) | 2013-09-17 | 2024-08-06 | Obi Pharma, Inc. | Compositions of a carbohydrate vaccine for inducing immune responses and uses thereof in cancer treatment |
| US11220523B2 (en) | 2014-03-13 | 2022-01-11 | Universität Basel | Carbohydrate ligands that bind to IgM antibodies against myelin-associated glycoprotein |
| CN108350605A (zh) * | 2015-09-04 | 2018-07-31 | 台湾浩鼎生技股份有限公司 | 聚糖阵列以及使用方法 |
| US10935544B2 (en) | 2015-09-04 | 2021-03-02 | Obi Pharma, Inc. | Glycan arrays and method of use |
| CN108026134A (zh) * | 2015-09-16 | 2018-05-11 | 巴塞尔大学 | 结合抗糖鞘脂糖蛋白表位抗体的碳水化合物配体 |
| US11091591B2 (en) | 2015-09-16 | 2021-08-17 | Universität Basel | Carbohydrate ligands that bind to antibodies against glycoepitopes of glycosphingolipids |
| US10980894B2 (en) | 2016-03-29 | 2021-04-20 | Obi Pharma, Inc. | Antibodies, pharmaceutical compositions and methods |
| US11041017B2 (en) | 2016-03-29 | 2021-06-22 | Obi Pharma, Inc. | Antibodies, pharmaceutical compositions and methods |
| US11833223B2 (en) | 2016-03-29 | 2023-12-05 | Obi Pharma, Inc. | Antibodies, pharmaceutical compositions and methods |
| US11583577B2 (en) | 2016-04-22 | 2023-02-21 | Obi Pharma, Inc. | Cancer immunotherapy by immune activation or immune modulation via Globo series antigens |
| US11642400B2 (en) | 2016-07-27 | 2023-05-09 | Obi Pharma, Inc. | Immunogenic/therapeutic glycan compositions and uses thereof |
| US11643456B2 (en) | 2016-07-29 | 2023-05-09 | Obi Pharma, Inc. | Human antibodies, pharmaceutical compositions and methods |
| US11000601B2 (en) | 2016-11-21 | 2021-05-11 | Obi Pharma, Inc. | Conjugated biological molecules, pharmaceutical compositions and methods |
| US12090212B2 (en) | 2016-11-21 | 2024-09-17 | Obi Pharma, Inc. | Conjugated biological molecules, pharmaceutical compositions and methods |
| US11203645B2 (en) | 2018-06-27 | 2021-12-21 | Obi Pharma, Inc. | Glycosynthase variants for glycoprotein engineering and methods of use |
Also Published As
| Publication number | Publication date |
|---|---|
| US9493580B2 (en) | 2016-11-15 |
| AU2011265184B2 (en) | 2016-08-04 |
| JP6050227B2 (ja) | 2016-12-21 |
| WO2011156774A3 (en) | 2012-04-19 |
| EP2579893A2 (en) | 2013-04-17 |
| WO2011156774A2 (en) | 2011-12-15 |
| US20130095173A1 (en) | 2013-04-18 |
| NZ604089A (en) | 2015-03-27 |
| CA2801922A1 (en) | 2011-12-15 |
| AU2011265184A1 (en) | 2013-01-10 |
| EP2579893A4 (en) | 2014-01-01 |
| JP2013528229A (ja) | 2013-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2011265184B2 (en) | Multivalent glycopeptide constructs and uses thereof | |
| US9598466B2 (en) | Glycopeptide constructs and uses thereof | |
| US10086054B2 (en) | RM2 antigens and use thereof | |
| JP6774943B2 (ja) | 極小サポニンアナログ、その合成および使用 | |
| US20260137789A1 (en) | Brush prodrugs and uses thereof | |
| US20260069700A1 (en) | Brush prodrugs and uses thereof | |
| CN111615400B (zh) | 作为治疗工具的精确糖缀合物 | |
| CN108778289A (zh) | 三萜皂苷类似物 | |
| US12084415B2 (en) | Biomolecule-polymer-pharmaceutical agent conjugates for delivering the pharmaceutical agent | |
| US20210085770A1 (en) | Neoglycoconjugates as vaccines and therapeutic tools | |
| AU2014271331A1 (en) | Glycopeptide constructs and uses thereof | |
| US20250114448A1 (en) | Saponin-based adjuvants and vaccines | |
| US20250092085A1 (en) | Saponin-based adjuvants and vaccines | |
| US20240308991A1 (en) | Process for the synthesis of reactive carbohydrates including antigen precursors for conjugation with a carrier material | |
| WO2024218268A1 (en) | Saponin derivatives as adjuvants and photoaffinity probes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130515 |